Riskpilot← Back to searchSign inGet full accessKAISO AS
ASActiveOrg 923199047Bulls Gate 2B, 3110 TønsbergTraditional, complementary and alternative medicine activities · NACE 8696Est. 20192 employees
Revenue 2025
NOK 1,2M
-53% vs 2024
EBITDA margin
7.6%
-75% vs 2024
Equity ratio
56.9%
Financial strength
Net profit 2025
NOK 9K
-89% vs 2024
| Revenue | NOK 1,2M | -53% |
| EBITDA | NOK 89K | -75% |
| Net profit | NOK 9K | -89% |
| Total assets | NOK 941K | +5% |
| Equity | NOK 536K | +94% |
| Employees | 2 | — |
Legal name
KAISO AS
Org number
923199047
Legal form
Aksjeselskap
NACE code
8696 · Traditional, complementary and alternative medicine activities
Founded
28. august 2019
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Kiropraktisk og nevrologisk rehabilitering/trening av pasienter. Handel, konsulentvirksomhet, investering i fast eiendom, deltagelser i andre selskaper og hva dermed står i forbindelse. Og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Bulls Gate 2B, 3110 Tønsberg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 887 | 2 354 | 2 380 | 2 474 | 1 174 |
| Staff expenses | −1 178 | −1 287 | −1 456 | −1 623 | −732 |
| EBITDA | 217 | 465 | 293 | 357 | 89 |
| Depreciation & amort. | −228 | −228 | −228 | −211 | −0 |
| EBIT | −11 | 237 | 65 | 146 | 89 |
| Net financials | −36 | −30 | −3 | 0 | 5 |
| Profit before tax | −47 | 207 | 62 | 146 | 94 |
| Tax | −0 | 47 | 44 | 62 | −0 |
| Net profit | −47 | 160 | 18 | 84 | 9 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 040 | 1 103 | 877 | 899 | 941 |
| Equity | 14 | 174 | 193 | 277 | 536 |
| Long-term debt | 825 | 445 | 165 | 125 | 0 |
| Short-term debt | 201 | 484 | 519 | 497 | 280 |
| Total debt | 1 026 | 929 | 684 | 622 | 405 |
EBITDA margin
7.6%
This company
15.8%
Market median
-52% vs market
20212025
Equity ratio
56.9%
This company
38.2%
Market median
+49% vs market
20212025
Return on equity
1.7%
This company
18.4%
Market median
-91% vs market
20212025
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20212025
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
20212025
Debt / equity
0.76×
This company
0.62×
Market median
+23% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HK Chief Executive Officer | Chief Executive Officer | 2019 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
KAISO AS 
KVANTUMKLINIKKEN ASBoard members of KAISO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Haakon Kuhnle Andresen | Chief Executive Officer | 0 companies |